Majid Momeny

2.7k total citations
85 papers, 2.1k citations indexed

About

Majid Momeny is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Majid Momeny has authored 85 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Majid Momeny's work include Retinoids in leukemia and cellular processes (14 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Acute Myeloid Leukemia Research (9 papers). Majid Momeny is often cited by papers focused on Retinoids in leukemia and cellular processes (14 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Acute Myeloid Leukemia Research (9 papers). Majid Momeny collaborates with scholars based in Iran, Finland and United States. Majid Momeny's co-authors include Seyed H. Ghaffari, Davood Bashash, Ahmad Reza Dehpour, Shayan Amiri, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Ava Safaroghli‐Azar, Mir‐Jamal Hosseini, Arya Haj‐Mirzaian and Jukka Westermarck and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Scientific Reports.

In The Last Decade

Majid Momeny

81 papers receiving 2.0k citations

Peers

Majid Momeny
Colin A. Flaveny United States
Jesse Alt United States
Jing Zhu China
Guillermo N. Armaiz-Peña United States
Jinjun Liu China
Dan Zhou China
Magnus Axelson Sweden
Paolo Gelosa Italy
Ken L. Chambliss United States
Antonio Ardizzoia Italy
Colin A. Flaveny United States
Majid Momeny
Citations per year, relative to Majid Momeny Majid Momeny (= 1×) peers Colin A. Flaveny

Countries citing papers authored by Majid Momeny

Since Specialization
Citations

This map shows the geographic impact of Majid Momeny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Majid Momeny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Majid Momeny more than expected).

Fields of papers citing papers by Majid Momeny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Majid Momeny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Majid Momeny. The network helps show where Majid Momeny may publish in the future.

Co-authorship network of co-authors of Majid Momeny

This figure shows the co-authorship network connecting the top 25 collaborators of Majid Momeny. A scholar is included among the top collaborators of Majid Momeny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Majid Momeny. Majid Momeny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghosh, Sukhen C., Vahid Khalaj, Ahmed O. Kaseb, et al.. (2025). Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications. Current Oncology. 32(9). 512–512. 1 indexed citations
2.
Momeny, Majid, Sukhen C. Ghosh, Vahid Khalaj, et al.. (2025). SSTR2-Targeted Theranostics in Hepatocellular Carcinoma. Cancers. 17(2). 162–162. 1 indexed citations
3.
Poursheikhani, Arash, Bahareh Kashani, Vahid Haghpanah, et al.. (2023). The effects of Abemaciclib on cell cycle and apoptosis regulation in anaplastic thyroid cancer cells. Molecular Biology Reports. 50(5). 4073–4082. 6 indexed citations
4.
5.
Momeny, Majid, et al.. (2021). Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: A proteomic study of molecular targets. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(10). 119087–119087. 15 indexed citations
6.
Momeny, Majid, Fatemeh Esmaeili, Sepideh Hamzehlou, et al.. (2019). The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells. Cellular Oncology. 42(4). 491–504. 20 indexed citations
7.
Pashaiefar, Hossein, Marjan Yaghmaie, Mohammad Ahmadvand, et al.. (2018). Low Expression of Long Noncoding RNA IRAIN Is Associated with Poor Prognosis in Non-M3 Acute Myeloid Leukemia Patients. Genetic Testing and Molecular Biomarkers. 22(5). 288–294. 35 indexed citations
8.
Pashaiefar, Hossein, Marjan Yaghmaie, Javad Tavakkoly‐Bazzaz, et al.. (2018). PARP-1 Overexpression as an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia. Genetic Testing and Molecular Biomarkers. 22(6). 343–349. 17 indexed citations
9.
Bashash, Davood, Ava Safaroghli‐Azar, Atieh Pourbagheri‐Sigaroodi, et al.. (2018). Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-κB axis: Shedding new light on resistance to Aprepitant. The International Journal of Biochemistry & Cell Biology. 103. 105–114. 25 indexed citations
10.
Panahi, Ghodratollah, Amir Rashidian, Mohammad Reza Hadian, et al.. (2018). The protective effects of sumatriptan on vincristine - induced peripheral neuropathy in a rat model. NeuroToxicology. 67. 279–286. 49 indexed citations
11.
Pashaiefar, Hossein, Marjan Yaghmaie, Javad Tavakkoly‐Bazzaz, et al.. (2018). Significance of PARP1 expression levels in patients with acute myeloid leukemia. Annals of Oncology. 29. ix87–ix87. 1 indexed citations
12.
Momeny, Majid, Ghazaleh Zarrinrad, Haniyeh Eyvani, et al.. (2017). Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells. Scientific Reports. 7(1). 45954–45954. 30 indexed citations
13.
Safaroghli‐Azar, Ava, et al.. (2017). PI3K-δ inhibition using CAL-101 exerts apoptotic effects and increases doxorubicin-induced cell death in pre-B-acute lymphoblastic leukemia cells. Anti-Cancer Drugs. 28(4). 436–445. 21 indexed citations
14.
Amini-Khoei, Hossein, Majid Momeny, Mohammad Abdollahı, et al.. (2016). Tropisetron suppresses colitis-associated cancer in a mouse model in the remission stage. International Immunopharmacology. 36. 9–16. 26 indexed citations
15.
Khan, Muhammad Imran, Sattar Ostadhadi, Faiza Mumtaz, et al.. (2016). Thalidomide attenuates the development and expression of antinociceptive tolerance to μ-opioid agonist morphine through l-arginine-iNOS and nitric oxide pathway. Biomedicine & Pharmacotherapy. 85. 493–502. 16 indexed citations
16.
Eyvani, Haniyeh, Ali Zekri, Majid Momeny, et al.. (2016). Arsenic trioxide induces cell cycle arrest and alters DNA methylation patterns of cell cycle regulatory genes in colorectal cancer cells. Life Sciences. 167. 67–77. 33 indexed citations
17.
18.
Ghaffari, Seyed H., et al.. (2014). Effect of Silibinin on the Metabolic Activity of the 8305c Cell Line in Thyroid Cancer. 3(12). 25–30. 1 indexed citations
19.
20.
Emami, Ali, Mehdi Yousefi, Abbas Mirshafiey, Majid Momeny, & Mohammad Reza Khorramizadeh. (2009). The Effects of Arsenic Trioxide and Zoledronic Acid on Malignant Plasma Cells Derived from Bone Marrow Cells of Multiple Myeloma Patients. SHILAP Revista de lepidopterología. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colin A. Flaveny Breakdown of academic impact, for papers by Jesse Alt Breakdown of academic impact, for papers by Jing Zhu Breakdown of academic impact, for papers by Guillermo N. Armaiz-Peña Breakdown of academic impact, for papers by Jinjun Liu Breakdown of academic impact, for papers by Dan Zhou Breakdown of academic impact, for papers by Magnus Axelson Breakdown of academic impact, for papers by Paolo Gelosa Breakdown of academic impact, for papers by Ken L. Chambliss Breakdown of academic impact, for papers by Antonio Ardizzoia
Rankless by CCL
2026